Cephalon/CIMA Merger Clears FTC: Generic Actiq To Ensure Price Competition

The Federal Trade Comission has taken the unprecedented step of allowing a brand name pharmaceutical manufacturer to establish a generic alternative for a drug rather than divest it to ensure market competition